In this issue
Experts in thoracic oncology from across the multidisciplinary team (MDT) explore the increasingly complex treatment landscape in metastatic EGFR-mutated non-small cell lung cancer (NSCLC), highlighting key factors and real-world challenges that influence clinical decision-making across the disease journey.
Rate this content's potential impact on patient outcomes
Average rating 0 / 5. Vote count: 0
No votes so far! Be the first to rate this content.
Latest articles
All articles

We’ve noticed you’re accessing
from North/South America.
from North/South America.